LORI SILVA: Open Payments
NPI 1891925327 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 2 | $292 |
| Madrigal Pharmaceuticals | 3 | $141 |
| SCPHARMACEUTICALS INC. | 1 | $135 |
| Lilly USA, LLC | 1 | $125 |
| Dynavax Technologies Corporation | 2 | $29 |
| Cipher Pharmaceuticals US LLC | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Livmarli, REZDIFFRA, FUROSCIX, MOUNJARO, Heplisav-B, Natroba, XIFAXAN.
Industry payments across TX — which companies pay providers there.
